Brief: Oramed Pharmaceuticals Says Appointed David Silberman, To Serve As CFO, Treasurer And Secretary, Effective July 5, 2021
26/05/2021 24:39
May 25 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED PHARMACEUTICALS - ON MAY 23 APPOINTED DAVID
SILBERMAN,
TO SERVE AS CFO, TREASURER AND SECRETARY, EFFECTIVE JULY 5, 2021
Source text: [ID: https://bit.ly/3oOUGk5]
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results